BEXIMCO PHARMACEUTICALS SPON GDR REP ONE ORD SH OF TAKA 10 REG SBEXIMCO PHARMACEUTICALS SPON GDR REP ONE ORD SH OF TAKA 10 REG SBEXIMCO PHARMACEUTICALS SPON GDR REP ONE ORD SH OF TAKA 10 REG S

BEXIMCO PHARMACEUTICALS SPON GDR REP ONE ORD SH OF TAKA 10 REG S

No trades
See on Supercharts

BXP fundamentals

An in-depth look to BEXIMCO PHARMACEUTICALS SPON GDR REP ONE ORD SH OF TAKA 10 REG S operating, investing, and financing activities

BXP free cash flow for Q3 24 is 12.29 M GBP. For 2023, BXP free cash flow was 29.65 M GBP and operating cash flow was 49.09 M GBP.

Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: GBP
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM
Free cash flowYoY growth